TapImmune Inc. Announces Initiation of Testing on Novel Cancer Vaccine

TapImmune, a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, announced FDA compliant testing company AppTec, headquartered in St. Paul, Minnesota, has begun preclinical testing of its lead product, a TAP-based therapeutic cancer vaccine.
Yahoo Finance